New results help predict treatment response in colorectal cancer
Tuesday, September 16, 2008 - 12:43
in Health & Medicine
Genetic testing can identify a group of patients with advanced colorectal cancer who are likely to survive on average twice as long if treated with the drug cetuximab, late breaking results show.